Immunic Inc (IMUX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Dr. Duane D. Nash
Employees:
87
1200 Avenue of the Americas Suite 200 New York, NY 10036
858-673-6840

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases, including relapsing-remitting multiple sclerosis, ulcerative colitis, Crohn's disease, and psoriasis.

Data derived from most recent annual or quarterly report
Market Cap 228.37 Million Shares Outstanding26.249 Million Avg 30-day Volume 353.984 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 28.21 / 6.96 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from IMUX instead.

View recent insider trading info

Funds Holding IMUX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IMUX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NASH DUANE EXECUTIVE CHAIRMAN

  • Officer
  • Director
15,032 2021-08-10 4

WHALEY GLENN PFO AND PAO

  • Officer
3,500 2021-08-10 3

VITT DANIEL PRESIDENT AND CEO

  • Officer
  • Director
363,877 2021-08-10 2

HOWSON TAMAR D

  • Director
10,000 2021-06-10 1

PHILLIPS BARCLAY A

  • Director
10,000 2021-06-10 1

OSSIPOW VINCENT

  • Director
25,000 2021-06-10 1

NEERMANN JOERG

  • Director
10,000 2021-06-10 1

VAN DEN BOSSCHE JAN

  • Director
10,000 2021-06-10 1

MUEHLER ANDREAS CHIEF MEDICAL OFFICER

  • Officer
294,486 2021-03-10 2

GROEPPEL MANFRED CHIEF OPERATING OFFICER

  • Officer
45,000 2021-03-01 1

PATEL SANJAY S CHIEF FINANCIAL OFFICER

  • Officer
0 2019-07-22 0

GLOBAL LIFE BIOVENTURE V SARL

OMEGA FUND V, L.P.

OMEGA FUND V GP, L.P.

OMEGA FUND V GP MANAGER, LTD.

LIM RICHARD J.

STAMPACCHIA OTELLO

NESSI CLAUDIO

PASTER ANNE-MARI

  • 10% Owner
1,371,494 2019-04-12 0

LSP V COOPERATIEVE U.A.

LSP V MANAGEMENT B.V.

  • 10% Owner
2,162,782 2019-04-12 0

FUND N.V.

  • 10% Owner
1,371,494 2019-04-12 0

DUNN JOHN MICHAEL GENERAL COUNSEL AND SECRETARY

  • Officer
0 2019-01-11 0

COX RUSSELL J. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-01-11 0

ASHLEY ROBERT A. CHIEF SCIENTIFIC OFFICER, EVP

  • Officer
0 2019-01-11 0

SWANSON MICHAEL V. CHIEF FINANCIAL OFFICER, EVP

  • Officer
0 2019-01-11 0

HALPERIN ERROL R.

  • Director
0 2018-09-25 0

BIENAIME JEAN JACQUES

  • Director
18,500 2018-09-24 0

GODSHALL DOUGLAS EVAN

  • Director
0 2018-09-19 0

SATTER MUNEER A

  • Director
  • 10% Owner
0 2018-09-13 0

HASNAIN FAHEEM

  • Director
8,000 2018-09-13 0

COHEN CHERYL

  • Director
0 2018-09-12 0

STERN ARON CHIEF ADMINISTRATIVE OFFICER

  • Officer
0 2018-07-01 0

MURAWSKI RICHARD M VICE PRESIDENT, MANUFACTURING

  • Officer
0 2018-06-09 0

HENRY ANDREW VP, CLINICAL OPERATIONS

  • Officer
0 2018-06-09 0

SEARS LOWELL

  • Director
0 2018-05-23 0

MILLIS J. MICHAEL

  • Director
0 2018-05-23 0

WINTERS TERENCE E. CO-CHAIRMAN AND CEO

  • Officer
  • Director
314,930 2017-06-14 0

STEER RANDOLPH C

  • Director
0 2017-05-23 0

CROXFORD PHILIP M

  • Director
0 2017-05-23 0

LOEWEN ANDREA SEE REMARKS

  • Officer
0 2016-05-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
IMMUNIC INC IMUX 2021-10-26 20:45:03 UTC -0.5675 0.6375 550000
IMMUNIC INC IMUX 2021-10-26 20:15:03 UTC -0.5675 0.6375 550000
IMMUNIC INC IMUX 2021-10-26 19:45:03 UTC -0.5675 0.6375 550000
IMMUNIC INC IMUX 2021-10-26 19:15:03 UTC -0.5675 0.6375 550000
IMMUNIC INC IMUX 2021-10-26 18:45:03 UTC -0.63 0.7 550000
IMMUNIC INC IMUX 2021-10-26 18:15:03 UTC -0.63 0.7 550000
IMMUNIC INC IMUX 2021-10-26 17:45:03 UTC -0.63 0.7 550000
IMMUNIC INC IMUX 2021-10-26 17:15:03 UTC -0.63 0.7 550000
IMMUNIC INC IMUX 2021-10-26 16:45:04 UTC -0.6176 0.6876 550000
IMMUNIC INC IMUX 2021-10-26 16:15:03 UTC -0.6176 0.6876 550000
IMMUNIC INC IMUX 2021-10-26 15:45:03 UTC -0.6176 0.6876 550000
IMMUNIC INC IMUX 2021-10-26 15:15:03 UTC -0.6176 0.6876 550000
IMMUNIC INC IMUX 2021-10-26 14:45:03 UTC -0.6781 0.7481 550000
IMMUNIC INC IMUX 2021-10-26 14:15:05 UTC -0.6781 0.7481 550000
IMMUNIC INC IMUX 2021-10-26 13:45:03 UTC -0.6781 0.7481 550000
IMMUNIC INC IMUX 2021-10-26 13:15:03 UTC -0.6781 0.7481 550000
IMMUNIC INC IMUX 2021-10-26 12:45:03 UTC -0.6781 0.7481 550000
IMMUNIC INC IMUX 2021-10-25 22:15:03 UTC -0.6781 0.7481 500000
IMMUNIC INC IMUX 2021-10-25 21:45:03 UTC -0.6781 0.7481 500000
IMMUNIC INC IMUX 2021-10-25 21:15:03 UTC -0.6781 0.7481 500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
ADVISORS' INNER CIRCLE FUND II- Hancock Horizon Quantitative Long/Short Fund IMUX -23170.0 shares, $-284064.2 2021-06-30 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund IMUX -8126.0 shares, $-71752.58 2021-07-31 N-PORT

Elevate your investments